Risk of Fractures Reduced in Polycystic Ovary Syndrome

This article originally appeared here.
Share this content:
Risk of Fractures Reduced in Polycystic Ovary Syndrome
Risk of Fractures Reduced in Polycystic Ovary Syndrome

MONDAY, Nov. 16, 2015 (HealthDay News) -- The risk of fractures is reduced in women with polycystic ovary syndrome (PCOS), according to a study published online Nov. 6 in the Journal of Bone and Mineral Research.

Katrine Hass Rubin, Ph.D., from the University of Southern Denmark in Odense, and colleagues examined fracture risk in patients with PCOS. Women with PCOS and/or hirsutism were identified from the Danish National Patient Register (19,199 women), and assigned three age-matched controls (57,483 women) on the index date of diagnosis of PCOS.

The researchers found that within the cohort, fracture rates were decreased for women with PCOS versus controls (10.3 versus 13.6/1,000 patient-years) The adjusted odds ratios were 0.76, 0.82, and 0.57 for all fractures, major osteoporotic fractures, and fractures of the head and face, respectively. Women diagnosed before age 30 years had more pronounced risk reduction. Women with PCOS had significantly more strain- and sprain-related hospital contact. Within a well-characterized subcohort of 1,217 women, the researchers observed no difference in the risk reduction in fractures for PCOS women with normal versus elevated testosterone levels; risk reduction was slightly smaller in overweight women.

"Women with PCOS had reduced risk of fractures, in particular of the appendicular skeleton," the authors write. "The risk reduction was greater in women with younger age at diagnosis, suggesting that the skeletal effects of PCOS may be greater in women who have not yet reached peak bone mass."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »